What are the neurologic complications of dengue infection?

Neurologic Complications of Dengue

Dengue infection can cause a wide spectrum of neurological complications including encephalitis, encephalopathy, Guillain-Barré syndrome, acute disseminated encephalomyelitis (ADEM), myelitis, stroke (both ischemic and hemorrhagic), seizures, cranial nerve palsies, and neuromuscular disorders—complications that occur in 0.5-21% of hospitalized dengue patients and account for 4-47% of encephalitis-like illnesses in endemic areas 1.

Primary Neurological Manifestations

The neurological complications can be systematically categorized into four main groups 2, 3, 1:

1. Encephalitis (Direct Viral Invasion)

• Results from dengue virus neurotropism and direct infection of CNS supporting cells
• Presents with altered consciousness, seizures, focal neurological deficits
• Pathogenesis involves direct neuro-invasion and antibody-dependent enhancement causing plasma leakage and coagulopathy 3

2. Encephalopathy (Indirect CNS Dysfunction)

• Secondary to metabolic derangements, hepatic failure, or systemic complications
• Distinguished from encephalitis by absence of direct viral CNS invasion
• More common than encephalitis in clinical practice 1

3. Immune-Mediated Neurological Syndromes

These develop through molecular mimicry mechanisms 3:

• Guillain-Barré syndrome (AIDP): Acute inflammatory demyelinating polyneuropathy
• Acute disseminated encephalomyelitis (ADEM): Occasionally encountered, may be steroid-responsive
• Acute transverse myelitis
• Miller-Fisher-like syndrome: Can occur with negative anti-GQ1b antibody
• Isolated cranial nerve palsies: Often steroid-responsive, may result from direct cranial nerve nuclei involvement or immune-mediated mechanisms 3
• Mononeuropathy

4. Vascular Complications

• Ischemic stroke: Pathogenesis extends beyond thrombocytopenia to include cerebral vasculitis 3
• Hemorrhagic stroke: Related to coagulopathy and thrombocytopenia
• Cerebral venous thrombosis 4
• Ocular vascular involvement: Maculopathy or retinal hemorrhages 3

Additional Neurological Syndromes

• Posterior reversible encephalopathy syndrome (PRES): Uncommon, possibly related to dysregulated cytokine release 4, 3
• Acute myositis and neuromuscular complications 4
• Hypokalemic paralysis: Must be screened in patients with acute neuromuscular weakness 3
• Memory loss and movement disorders: Particularly in adults ≥60 years during DENV serotype 3 transmission 5

Clinical Recognition and Timing

Critical clinical point: Neurological manifestations should be suspected in any patient with fever and acute neurological symptoms in dengue-endemic areas or after travel to these regions 1. The 2009 WHO classification now formally recognizes neurological manifestations as part of severe dengue criteria 6, 1.

Temporal Patterns:

• Acute phase: Encephalitis, encephalopathy, seizures occur during active infection
• Post-infectious (within 2 weeks): Guillain-Barré syndrome, ADEM, and other immune-mediated complications 3
• Risk trajectory: Neurological events show diverging risk up to 90 days post-infection 5

Risk Factors and Burden

From the most recent population-based cohort study 5:

• At 30 days post-infection, dengue patients had 9.69-fold increased odds of any new neurological event (95% CI: 6.59-14.90)
• Memory loss: 3.19-fold increased odds (95% CI: 1.36-8.69)
• Movement disorders: 7.10-fold increased odds (95% CI: 2.49-29.18)
• Other neurological events: 14.32-fold increased odds (95% CI: 8.61-26.04)

However, the absolute excess burden is modest at <1 excess event per 100 cases 5.

High-Risk Populations:

• Adults ≥60 years: Significantly elevated risk for memory loss (aOR 2.99) and movement disorders (aOR 6.38) 5
• Pediatric patients: Some reports suggest higher incidence of cardiac complications, though neurological data are less specific 7
• Severe dengue cases: Those with warning signs or meeting severe dengue criteria

Diagnostic Considerations

Important caveat: Neurological complications are likely significantly underdiagnosed due to non-specific symptoms, limited imaging access, and predominant clinical focus on hemorrhagic outcomes 7. In endemic areas, only a small percentage of dengue patients receive neurological evaluation 7.

Differential Diagnosis Priority:

When evaluating acute febrile encephalopathy in endemic areas, consider 3:

• Other arboviral encephalitides (Japanese encephalitis, West Nile, Zika)
• Autoimmune encephalitides
• SARS-CoV-2-related encephalopathy
• Bacterial meningitis
• Other causes of isolated cranial nerve palsies (even if dengue confirmed)

Management Implications

No specific antiviral treatment exists for dengue neurological complications 4. Management is primarily supportive with attention to:

• Hydration: Paramount during early stages 4
• Immune-mediated complications: High-dose corticosteroids for ADEM (B-III recommendation from encephalitis guidelines) 8
• Cranial nerve palsies: Often steroid-responsive 3
• Monitoring: Older adults require vigilant monitoring for broader spectrum of neurological complications 5

Critical Screening Algorithm:

Any patient developing acute neuromuscular weakness during or within 2 weeks of dengue remission must be screened for 3:

1. Acute inflammatory demyelinating polyneuropathy (AIDP)
2. Hypokalemic paralysis
3. Acute myositis

Key Clinical Pitfalls

1. Atypical presentations in older adults: Diagnosis can be difficult due to non-specific symptoms 9
2. Overlap syndromes: Categories of neurological complications can overlap, making classification challenging 1
3. Delayed immune-mediated complications: Can occur up to 2 weeks post-recovery
4. Underdiagnosis: Cardiovascular and neurological complications receive less attention than hemorrhagic manifestations 7